Patterns of opportunistic infections in patients with HIV infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 1, 1996, Pages 38-45

  Finkelstein, Dianne M ^a   Williams, Paige L ^a   Molenberghs, Geert ^a   Feinberg, Judith ^b   Powderly, William G ^c   Kahn, James ^d   Dolin, Raphael ^e   Cotton, Deborah ^f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cytomegalovirus infection; Mycobacterium avium complex; Opportunistic infections; Pneumocystis carinii pneumonia; Prophylactic therapies; Proportional hazards model; Relative risk; Systemic mycosis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MYCOBACTERIOSIS; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; SYSTEMIC MYCOSIS;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM COMPLEX (MAC); PNEUMOCYSTIS CARINII;

EID: 0029966399     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199605010-00006     Document Type: Article

References (15)

1. CDC Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 1986;35:334-9.
2. Saag MS. Natural history of HIV-1 Disease. In Broder S, Merigan TC, Bolognesi D (eds). Textbook of AIDS medicine, Baltimore: Williams & Wilkins, 1994:45.
3. Bozzette SA, Finkelstein DM, Spector SA, et al.; A randomized clinical trial of three anti-pneumocystis agents in patients with advanced HIV infection. N Engl J Med 1995;332 (11):693-9.
4. Nightingale SD, Cameron DW, Gordin FM. Two controlled trials of rifabutin prophylaxis against MAC infection in AIDS. N Engl J Med 1993;329:828-33.
5. Powderly WG, Finkelstein DM, Feinberg J, et al.; A randomized clinical trial of fluconazole versus clotrimazole troches for the prevention of fungal infections in patients with advanced HIV infection. N Engl J Med 1995;332(1):700-5.
6. Cotton D, Weinrib D. Survey results: treatment decisions in HIV care. AIDS Clinical Care 1992;4:85-91.
7. Fogelman I, Lim L, Bassett R, Volberding P, Fischl MA, Stanley K, Cotton DJ for the AIDS Clinical Trials Group (ACTG). Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type I clinical trials. J Acquir Immune Defic Syndr 1994;7:1057-63.
8. Akova A, Akalin HE, Ozun O, Gur D. Emergence of Candida kruseii infections after treatment of oropharyngeal candidiasis with fluconazole. Eur J Clin Microbiol Infect Dis 1991;10:598-9.
9. + lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis 1992; 165:352-63.
10. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A; the Multicenter AIDS Cohort Study Group. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type I. N Engl J Med 1990; 332:161-5.
11. Dolin R, Amato D, Fischl MA, et al.; Zidovudine compared with didanosine in patients with advanced human immunodeficiency virus type 1 infection and little or no previous experience with zidovudine. Arch Intern Med 1995;155:961-74.
12. Kahn JO, Lagakos SW, Richman DD, et-al.; AIDS Clinical Trials Group. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N Engl J. Med 1992;327:581-57.
13. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE; Zidovudine Epidemiology Study Group. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992;166:1223-7.
14. Horsburgh CR, Havlik JA, Ellia DA, et al. Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis 1991;144:557-9.
15. Cox DR. Regression models and life-tables (with discussion). J Roy Statist Soc Ser B 1972;34:187-220.